<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//psychogenicsv30.kinsta.cloud/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-awarded-nih-heal-initiative-contract-for-preclinical-screening-platform-for-pain-pspp-3/</loc>
		<lastmod>2025-07-18T09:44:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-appoints-mark-a-varney-phd-as-chief-scientific-officer/</loc>
		<lastmod>2025-07-18T09:44:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/sunovion-and-psychogenics-initiate-diamond-phase-3-clinical-studies-for-sep-363856-in-the-treatment-of-adults-and-adolescents-with-schizophrenia/</loc>
		<lastmod>2025-07-18T09:45:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/sunovion-and-psychogenics-announce-that-sep-363856-has-received-fda-breakthrough-therapy-designation-for-the-treatment-of-people-with-schizophrenia/</loc>
		<lastmod>2025-07-18T09:45:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-announces-exclusive-global-license-for-an-ind-ready-ent1-inhibitor-for-the-treatment-of-neuropsychiatric-disorders/</loc>
		<lastmod>2025-08-20T11:42:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-launches-updated-corporate-identity-and-brand/</loc>
		<lastmod>2025-08-20T11:55:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-awarded-an-nih-contract-to-test-and-identify-novel-therapeutics-for-pain/</loc>
		<lastmod>2025-08-21T11:57:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-achieves-top-supplier-status-on-scientist-com-for-2023/</loc>
		<lastmod>2026-01-06T16:19:10+00:00</lastmod>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2024/01/PsychoGenics.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-launches-ecube-a-new-ai-enabled-platform-for-drug-discovery/</loc>
		<lastmod>2026-01-20T10:02:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-ceo-explores-cns-drug-development-trends/</loc>
		<lastmod>2026-01-20T10:43:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/why-psychogenics-and-emyria-are-collaborating-to-examine-mdma-inspired-compounds/</loc>
		<lastmod>2026-01-20T10:45:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-announces-extension-of-ongoing-drug-discovery-collaboration-with-karuna-therapeutics/</loc>
		<lastmod>2026-01-20T10:47:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/emyria-starts-program-with-neuroscience-drug-discovery-cro/</loc>
		<lastmod>2026-01-20T10:56:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/clinical-catch-up-updates-in-solid-tumors-als-migraine-and-more/</loc>
		<lastmod>2026-01-20T10:57:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/emyria-teams-with-cro-psychogenics-for-mdma-like-drug-development/</loc>
		<lastmod>2026-01-20T10:59:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/industrializing-behavioral-testing-to-redefine-neuropsychiatric-drug-discovery-2/</loc>
		<lastmod>2026-01-20T11:07:54+00:00</lastmod>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2022/08/nature-research-logo-300x117-1.webp</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2022/08/psychogenics-logo-300x103-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/we-need-a-new-prozac-the-demand-for-brain-drug-innovation/</loc>
		<lastmod>2026-01-20T11:11:20+00:00</lastmod>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2022/08/we-need-new-prozac.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2022/08/figure-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://psychogenicsv30.kinsta.cloud/wp-content/uploads/2022/08/figure-2.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/mental-health-champions-why-how-dr-emer-leahy-of-psychogenics-is-helping-to-champion-mental-wellness/</loc>
		<lastmod>2026-01-20T11:13:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/the-cns-drug-development-drum-beat-is-getting-louder-2/</loc>
		<lastmod>2026-01-20T11:16:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-strengthens-executive-team-to-boost-cns-drug-discovery-and-cro-capabilities/</loc>
		<lastmod>2026-01-20T11:30:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/gbr-connect-series-interview-with-emer-leahy-psychogenics/</loc>
		<lastmod>2026-01-20T11:33:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-high-data-security-standards-are-certified-by-the-nih/</loc>
		<lastmod>2026-01-20T11:39:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-appoints-dr-stephen-morairty-and-jean-sebastien-valois-as-vps/</loc>
		<lastmod>2026-01-20T16:38:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-chief-innovation-officer-honored-for-scientific-excellence/</loc>
		<lastmod>2026-01-20T16:44:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-further-strengthens-its-leadership-team-adding-three-senior-executives/</loc>
		<lastmod>2026-01-20T16:55:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-drug-discovery-featured-in-nature/</loc>
		<lastmod>2026-01-20T17:24:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/karuna-therapeutics-and-psychogenics-announce-drug-discovery-collaboration-2/</loc>
		<lastmod>2026-01-21T09:43:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-inc-awarded-3-million-sbir-grant-to-employ-its-ai-enabled-platforms-to-find-treatments-for-rare-disorders/</loc>
		<lastmod>2026-01-23T10:25:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/new-breakthroughs/</loc>
		<lastmod>2026-01-23T10:28:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-and-collaborations-pharmaceuticals-awarded-1m-grant-to-use-ai-platforms-to-design-new-drugs-for-mental-health-disorders/</loc>
		<lastmod>2026-01-23T10:59:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://psychogenicsv30.kinsta.cloud/about/news/psychogenics-highlights-a-long-term-collaboration-with-the-tsc-alliance-on-rare-disease-day/</loc>
		<lastmod>2026-01-23T11:01:14+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->